611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line

NurseWise 24-Hour Crisis Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...

Health Sciences
Basic InformationLatest News
'Fountain of Youth' Gene Discovered in Secluded Amish CommunityLRRK2 Variants Linked to Lower Age at Onset of Parkinson'sKnowing Too Much About Your Genes Might Be RiskyOverlapping Surgery Appears Safe in Neurosurgical ProceduresDo I Know Ewe?Daytime Wounds May Heal Faster Than Nighttime OnesHuman vs. Animal Brainpower: More Alike Than You Might ThinkResilient Brain Connections May Help Against Alzheimer'sConcerns Surround Use of Direct-to-Consumer Genetic TestingWhen It Comes to Obesity, Genes Just Partly to BlameDoes Time of Neurosurgery Matter?Smoking Alters Genetic Relationship with Parkinson'sHealth Tip: Considering Genetic TestingDiabetes Ups Risk of MACE in Acute Coronary SyndromesScientists Spot Genes Behind Skin ColorScientists Support Genome Editing to Prevent DiseaseBrain Disconnects Spotted in Parkinson's Patients With Visual HallucinationsCoffee Doesn't Help Parkinson's Motor DisordersCan Babies Help Heart Patients?Scientists Spot Marker for CTE in Living Football PlayersNerve Stimulation Pulls Patient From 15-Year Vegetative StateWhy Your Nose May Be Key to Parkinson's RiskEvolution Not Over for HumansBrain Scans Offer Clues to Why Some Teens Pile on PoundsNew Clues to Why Yawns Are ContagiousNew Hope From Old Drugs in Fight Against Parkinson'sFirst Gene Therapy Approved in U.S.Awake for Aneurysm Brain Surgery, Better Results?Does Autism Risk Reside in Cells' Energy Engines?More Evidence Contact Sports Can Affect the BrainVirtual House Calls for Speedy, Effective Parkinson's CareSeven Imaging Biomarkers Tied to Cognition in Male FightersDiabetes Drug Shows Promise Against Parkinson'sCombined MRI Might Help Predict Brain Damage in BoxersMedical Reality Catches Up to Science FictionNoninvasive Brain Test May Pinpoint Type of DementiaIn Mice, Brain Cells Discovered That Might Control AgingScans May Show Consciousness in 'Comatose' PatientsBoxers, MMA Fighters May Face Long-Term Harm to Brain: StudyFDA Panel OKs What May Soon Be First Gene Therapy Approved in U.S.Early Parkinson's May Prompt Vision ProblemsWhole-Genome Sequencing of Uncertain Clinical UtilityCould Shift Work Damage Your DNA?Gene Sequencing May Reveal Risks for Rare DiseasesRogue Genes May Cause Some ALS CasesSticky Brain 'Plaques' Implicated in Alzheimer's AgainEven Your Bones Can Get Fat, Mouse Study SuggestsDoes a Low-Fat Dairy Habit Boost Parkinson's Risk?MicroRNA Biomarker Signature Identified for Allergic AsthmaHaywire Immune Cells May Help Cause Baldness
Questions and AnswersLinksBook Reviews
Related Topics

Medical Disorders
Mental Disorders
Mental Health Professions

Is It Parkinson's or Something Else? Blood Test Might Tell

HealthDay News
by By Amy NortonHealthDay Reporter
Updated: Feb 8th 2017

new article illustration

WEDNESDAY, Feb. 8, 2017 (HealthDay News) -- Measuring a particular blood protein might help doctors easily distinguish Parkinson's disease from some similar disorders, a new study suggests.

The potential blood test is "not ready for prime time," Parkinson's disease experts said. But, it marks progress in the quest for an objective way to diagnose Parkinson's and similar conditions known as atypical parkinsonian disorders, they noted.

Parkinson's disease is a movement disorder that affects nearly 1 million people in the United States alone, according to the Parkinson's Disease Foundation.

The root cause is unclear, but as the disease progresses, the brain loses cells that produce dopamine -- a chemical that regulates movement. As a result, people suffer symptoms such as tremors, stiff limbs, and balance and coordination problems that gradually worsen over time.

Right now, there is no blood test, brain scan or other objective measure that can definitively diagnose Parkinson's, said James Beck, vice president of scientific affairs for the Parkinson's Disease Foundation.

"In general, Parkinson's disease is diagnosed with a clinical exam," Beck explained.

The best person to make that call is a neurologist with expertise in movement disorders, according to Beck.

"But," he said, "even highly trained doctors initially get it wrong about 10 percent of the time."

In the earlier stages, Beck said, Parkinson's symptoms can be very similar to those of atypical parkinsonian disorders, or APDs.

APDs are fairly rare, and include conditions known as progressive supranuclear palsy, corticobasal syndrome and multiple system atrophy.

There is no cure for Parkinson's or APDs, or any way to halt their progression.

But it's important to distinguish between the two as early as possible, said the study's lead author Dr. Oskar Hansson. He's a researcher at Lund University in Sweden.

That's because the course of an APD differs from that of Parkinson's, Hansson explained.

"Patients with APD do usually have a much worse prognosis, with faster disease progression and more disabling symptoms," he said.

Plus, Hansson noted, their symptoms usually don't respond well to the dopamine-targeting medications used to manage Parkinson's. Patients with APDs may need more intensive management with a "team of movement disorder specialists," he said.

The new study, published online Feb. 8 in Neurology, focused on a blood protein called neurofilament light chain (NfL). It's a component of nerve cells that is released when the cells die.

Research has shown that people with APDs show elevated levels of NfL in their spinal fluid. But the only way to test for that is through a painful lumbar puncture.

Hansson's team recently developed an "ultrasensitive" test that can pick up NfL in the blood. So they looked at whether the test might distinguish Parkinson's patients from those with APDs.

To do that, they studied over 500 people from Sweden or England. The study participants were placed into one of three groups. Two groups included healthy people and patients who'd been living with Parkinson's or APDs for four to six years. The third group included people who'd been diagnosed with the diseases more recently -- within the past three years.

Overall, the study found, APD patients had higher NfL levels than either Parkinson's patients or healthy people.

The test did appear more accurate in patients who'd had the disorders for a longer time, Beck pointed out. Among those patients, the test had a "sensitivity" of 80 to 82 percent; sensitivity refers to the percentage of people with a condition who are accurately identified as "positive."

In the group with earlier-stage Parkinson's or APDs, the test sensitivity was 70 percent.

The blood test still needs refinement and should be studied in larger groups of patients, Beck said.

And for the test to be used in everyday practice, he added, there has to be a "standardized protocol" for how it's performed. "How reliably can this test be done, site to site?" Beck said.

Hansson made the same point. One of the next steps, he said, will be to "establish a cut-off value that can be used with high precision in different labs around the world."

The study is far from the first to look at a potential blood test to help in diagnosing Parkinson's. But previous tests have been aimed at identifying Parkinson's early, according to Beck.

The NfL test is different, he said, because it specifically aims to distinguish APDs from Parkinson's when patients' symptoms make it a tough call.

As for those other blood tests, nothing has panned out yet. "But it's not for lack of trying," Beck said. "Scientists are exploring different avenues to come up with a reliable test."

More information

The Parkinson's Disease Foundation has more on coping with a diagnosis.